StepWise USMLE
IMMUNOLOGY Β· TISSUE INJURY

Hypersensitivity & Autoimmunity

A working map of the four patterns by which immune responses injure the body's own tissues, and how tolerance normally keeps that from happening.

The Big Picture

framework

What Counts as a Hypersensitivity Reaction

  • An immune response that damages the host rather than only clearing a threat
  • Trigger can be a harmless foreign substance (pollen, a drug) or a self-molecule
  • When the target is self, the process is called autoimmunity specifically

Two Variables That Shape the Outcome

  • Which arm of immunity does the damage
    • Antibody-driven vs. cell-driven
  • Where the target antigen sits
    • Fixed in one tissue β†’ localized disease
    • Circulating or widely distributed β†’ systemic disease

Shared Timeline Across All Four Patterns

First encounter→ Immune system primed→ Repeat encounter→ Injury manifests
  • Reaction is antigen-specific, not a generic overreaction
  • Cross-reactive molecules can trigger the same primed response
PatternMain DriverSpeedDistribution
IIgE + mast cellsMinutesLocal or systemic
IIIgG/IgM vs. fixed antigenHours–daysTissue-specific
IIICirculating immune complexesDaysSystemic, vessel-prone
IVT cells1–3 daysLocalized

Fast & Antibody-E-Driven Reactions

Type I

Core Identity

  • Only pattern built on IgE
  • Symptoms appear within minutes of re-exposure
  • Evolutionarily meant to expel large parasites too big to phagocytose
  • About one in five people mount this response against harmless environmental triggers (pet dander, pollen) β€” termed atopy

How Sensitization Happens

  1. Antigen enters via mucosa or skin
  2. Helper T cells polarize toward a Th2 program
  3. Th2 cytokines (IL-4, IL-13) drive B cells to class-switch to IgE
  4. IgE coats mast cells and basophils via high-affinity Fc receptors
  5. On re-exposure, antigen bridges adjacent IgE molecules
  6. Bridging triggers degranulation

What Comes Out of the Granules

Mediator classExampleEffect
Preformed amineHistamineVessel leak, smooth muscle spasm
Preformed enzymeTryptaseLocal tissue remodeling
Lipid mediator (new)Leukotrienes, prostaglandinsProlonged constriction, more leak
CytokineTNFSustains inflammation, recruits cells

Two Waves

Immediate wave (min)β†’ Late-phase wave (2–4 hr, lipid-driven)

Clinical Faces of Type I

  • Allergic rhinitis β€” nasal edema and mucus from airborne allergens
  • Asthma β€” bronchoconstriction and mucus plugging from inhaled triggers
  • Food allergy β€” hives and GI upset
  • Systemic anaphylaxis β€” widespread vasodilation, airway compromise, can be fatal
  • Wheal-and-flare β€” the local skin reaction used diagnostically
  • Anaphylaxis differs from local allergy mainly by scale: the same mediators released everywhere at once can cause vascular collapse.

Antibody vs. Surface Targets

Type II

Core Identity

  • IgG or IgM binds an antigen fixed to a cell surface or extracellular matrix
  • Because the target doesn't circulate, damage stays confined to that tissue
  • Antigen is usually self, occasionally a foreign molecule that cross-reacts with self

Three Ways the Antibody Can Hurt

  • Opsonization β†’ faster phagocytic clearance of the coated cell
  • Complement fixation β†’ membrane attack complex or recruitment of neutrophils/macrophages
  • Receptor interference β†’ antibody blocks or stimulates a receptor without killing the cell

Two Functional Subtypes

Cytotoxic (kills the cell) Non-cytotoxic (alters cell behavior only)
DiseaseTargetCategoryResult
Autoimmune hemolytic anemiaRBC membrane proteinsCytotoxicHemolysis
Goodpasture diseaseType IV collagen (kidney/lung basement membrane)CytotoxicNephritis + lung hemorrhage
Rheumatic feverStrep antigen cross-reacting with heartCytotoxicMyocarditis, arthritis
Transfusion reactionABO antigensCytotoxicAcute hemolysis
Immune thrombocytopeniaPlatelet proteinsCytotoxicBleeding
Myasthenia gravisAcetylcholine receptorNon-cytotoxic (blocking)Weakness
Graves diseaseTSH receptorNon-cytotoxic (stimulating)Hyperthyroidism
Pernicious anemiaIntrinsic factorNon-cytotoxic (neutralizing)B12 malabsorption
  • Hemolytic disease of the newborn arises when an Rh-negative mother makes IgG against fetal Rh-positive red cells after a sensitizing first delivery, and that IgG crosses into a later Rh-positive pregnancy.
  • Giving anti-D antibody to the mother around delivery clears fetal cells before her own B cells can form memory against them, preventing the next pregnancy's disease.

Complexes Gone Astray

Type III

Core Identity

  • Antibody binds soluble antigen while still in circulation, forming a complex
  • Complexes lodge wherever blood filters through narrow vessels β€” kidney glomeruli, joints, skin
  • Damage site therefore has little to do with where the antigen originated
  • Because the trigger circulates, disease tends to be systemic rather than one-organ

Injury Mechanism

Complex deposits in vessel wall→ Complement activation→ Neutrophil recruitment→ Vasculitis / nephritis / arthritis
DiseaseAntigenPresentation
Systemic lupus erythematosusDouble-stranded DNA, nucleoproteinsMalar rash, nephritis, arthritis, vasculitis
Post-streptococcal glomerulonephritisStrep cell-wall antigenGranular ("lumpy-bumpy") deposits, nephritis
Arthus reactionAny locally injected proteinLocalized pain and edema
Serum sicknessForeign serum proteinsArthritis, vasculitis, nephritis days after exposure
Polyarteritis nodosaHepatitis B antigenSystemic vasculitis

Related Antinuclear-Antibody Diseases

  • Diffuse systemic sclerosis β†’ antibody to DNA topoisomerase I
  • Limited scleroderma (CREST) β†’ anti-centromere antibody
  • SjΓΆgren syndrome β†’ antibody to ribonucleoproteins

Slow-Burn T-Cell Attack

Type IV

Core Identity

  • Only pattern with no antibody involvement β€” driven entirely by T lymphocytes
  • Onset is delayed, typically one to three days after re-exposure
  • Same machinery normally clears intracellular pathogens, so injury is a side effect of a legitimate defense program

Two Routes to Damage

  • Cytokine-mediated
    • CD4+ Th1 cells release interferon-gamma β†’ activates macrophages
    • CD4+ Th17 cells release IL-17 β†’ recruits neutrophils
  • Direct cytotoxic killing
    • CD8+ cytotoxic T cells lyse the target cell directly
DiseaseT-cell targetManifestation
Tuberculin skin testMycobacterial proteinIndurated papule
Contact dermatitisNickel, poison-ivy resin (as haptens)Vesicular rash
Hashimoto thyroiditisThyroid antigenHypothyroidism
Multiple sclerosisMyelin basic proteinDemyelination, visual/motor deficits
Rheumatoid arthritisJoint synovium antigenChronic joint destruction
Type 1 diabetesIslet-cell antigensBeta-cell loss, hyperglycemia
Guillain-BarrΓ© syndromePeripheral nerve myelinAscending paralysis
Celiac diseaseGliadin-derived peptidesSmall-bowel villous injury
  • Several of these diseases also produce autoantibodies (rheumatoid factor, anti-CCP, islet autoantibodies) that serve as useful lab markers even though the tissue injury itself is T-cell driven.

When Self-Recognition Fails

Autoimmunity

The Starting Point

  • Autoreactive lymphocytes recognize a self-antigen, then activate, expand, and differentiate into damaging effectors
  • Requires an upstream failure of central tolerance β€” the education process lymphocytes undergo in bone marrow and thymus

Peripheral Tolerance β€” the Backup System

  • Anergy
    • B cells: self-recognition without T-cell help drives high surface IgD, exclusion from lymphoid tissue, and eventual death
    • T cells: failure of T-cell-receptor signaling, or engagement of inhibitory receptors CTLA-4 / PD-1
  • Deletion
    • Self-reactive T cells undergo apoptosis via caspase or Fas signaling
  • Suppression
    • Regulatory T cells secrete IL-10 and TGF-beta to dampen lymphocyte, macrophage, and dendritic cell activation
    • Regulatory T cells express abundant CTLA-4, which sequesters the costimulatory molecule B7 away from other T cells

What Tips the Balance Toward Disease

  • Genetic susceptibility β€” HLA alleles are the strongest known association
  • Non-HLA gene polymorphisms
  • Environmental triggers, including infection
  • Hormonal influences
DiseaseLinked HLA allele
Rheumatoid arthritisDR4
Type 1 diabetesDR3 / DR4
Multiple sclerosis, GoodpastureDR2
Systemic lupus erythematosusDR2 / DR3
Ankylosing spondylitis, psoriasis, reactive arthritisB27
Celiac diseaseDQ2 or DQ8
Graves diseaseB8

Why Autoimmune Disease Tends to Persist

  • Infection or tissue damage can change how self-antigens are displayed, providing the initial trigger
  • Injury to one self-antigen can expose additional self-antigens to the immune system
  • This spreading exposure is why these diseases are typically chronic and progressive rather than self-limited